QCG
SWTX

Quadrant Capital Group’s SpringWorks Therapeutics SWTX Stock Holding History

Quadrant Capital Group’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100
Closed -$3.61K – 2839
2024
Q4 		$3.61K Buy
+100
New +$3.49K ﹤0.01% 2382
2024
Q2 		– Sell
-23
Closed -$1.13K – 2765
2024
Q1 		$1.13K Buy
+23
New +$1.06K ﹤0.01% 2578
2023
Q4 		– Sell
-52
Closed -$1.2K – 2782
2023
Q3 		$1.2K Hold
52
– – ﹤0.01% 2464
2023
Q2 		$1.36K Hold
52
– – ﹤0.01% 2471
2023
Q1 		$1.34K Hold
52
– – ﹤0.01% 2498
2022
Q4 		$1.35K Sell
52
-17
-25% -$419 ﹤0.01% 2489
2022
Q3 		$2K Sell
69
-95
-58% -$2.72K ﹤0.01% 2428
2022
Q2 		$4K Buy
+164
New +$6K ﹤0.01% 2057

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return